Alabama 2023 Regular Session

Alabama House Bill HB227

Introduced
4/4/23  

Caption

Relating to medical cannabis; to amend Sections 20-2A-3, 20-2A-8, 20-2A-21, 20-2A-32, 20-2A-36, and 20-2A-64, Code of Alabama 1975, to further provide for the conditions that are considered a qualifying medical condition; to further restrict individuals from having an economic interest in a licensee and to establish a time period for the prohibition; to further provide for the definition of a registered certifying physician and provide that a registered certifying physician may only certify a patient for medical cannabis use if he or she is board certified in the field of specialty required to diagnose a qualifying medical condition as provided by law; to prohibit a non-registered certifying physician from having a financial arrangement with a registered certifying physician for patient referrals; to provide that an individual cannot qualify as a registered caregiver if he or she is also a qualified registered patient; to further provide for location restrictions and dispensing protocols for a dispensary; to make it a crime for an individual to sell a medical cannabis card; and in connection therewith would have as its purpose or effect the requirement of a new or increased expenditure of local funds within the meaning of Section 111.05 of the Constitution of Alabama of 2022.

Impact

The new provisions introduced by HB 227 could significantly impact both the medical community and potential patients by making medical cannabis more accessible under broadened criteria. It is designed to tighten regulatory controls over who can dispense and certify patients for medical cannabis, aiming to reduce fraud and abuse. By restricting the ability of non-registered certifying physicians to have financial arrangements related to referrals, the bill seeks to uplift ethical standards within cannabis management. The amendments to the operational framework for dispensaries are expected to enhance compliance and accountability, making the process for acquiring cannabis more transparent for users, although some local governments may face increased expenditures.

Summary

House Bill 227 aims to amend existing regulations surrounding medical cannabis use in Alabama. This bill expands the list of qualifying medical conditions for which patients may receive medical cannabis, fundamentally altering how patients can access these services. Notably, the bill lays out precise definitions for qualified patients and caregivers, specifying that caregivers must not also be patients themselves. It aims to refine the operational definitions related to certified physicians who specialize in diagnosing qualifying conditions, establishing that only board-certified physicians can certify patients for cannabis use. Additionally, the bill strengthens regulations concerning economic interests, disallowing individuals who are members of the Alabama Medical Cannabis Commission from having financial ties to licensees.

Contention

Critics of HB 227 may voice concerns regarding the restrictions on caregivers and the definition parameters for physicians, arguing that this could limit patients' access to necessary care. The opposition highlights that burdening patients with the requirement of exclusively dealing with board-certified physicians may deter some from seeking medical cannabis altogether. There is also concern that increasing the regulatory burden on dispensaries could limit the number of establishments, leading to potential shortages of cannabis in underserved areas. These points have formed the crux of debates surrounding the bill, balancing regulatory needs with patient accessibility.

Companion Bills

No companion bills found.

Similar Bills

AZ SB1715

Hemp-derived manufactured impairing cannabinoids

NJ S2392

Authorizes medical cannabis for treatment of sickle cell anemia.

SC H3019

Put Patients First Act

CT HB05450

An Act Concerning The Palliative Use Of Marijuana.

AL HB390

Alabama Medical Cannabis Commission; primary responsibility over regulation, licensing, and enforcement of cannabis cultivation authorized

NJ A913

Authorizes medical cannabis for treatment of sickle cell anemia.

CT HB05389

An Act Concerning The Palliative Use Of Marijuana.

AZ HB2828

Department of marijuana regulation